Kobayashi Pharmaceutical Co., Ltd. Share Price Deutsche Boerse AG
Stocks
KOY
JP3301100008
Personal Products
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
07:01:11 25/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 29.60 EUR | +0.68% |
|
+2.07% | +3.50% |
| Market Cap | 422B 2.65B 2.27B 2.13B 1.94B 3.67B 253B 3.7B 24.87B 9.75B 128B 9.96B 9.74B | P/E 2026 * |
41.5x | P/E 2027 * | 31.1x |
|---|---|---|---|---|---|
| Enterprise Value | 364B 2.29B 1.96B 1.83B 1.68B 3.17B 218B 3.19B 21.46B 8.41B 110B 8.59B 8.41B | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.96x |
| Free-Float |
64.44% | Yield 2026 * |
1.87% | Yield 2027 * | 1.93% |
| 1 day | +0.68% | ||
| 1 week | +2.07% | ||
| Current month | +0.68% | ||
| 1 month | +4.96% | ||
| 3 months | -3.90% | ||
| 6 months | -1.99% | ||
| Current year | +3.50% |
| 1 week | 29 |  | 29.6 |
| 1 month | 28.8 | | 31.2 |
| Current year | 27.6 | | 32 |
| 1 year | 27.4 | | 32 |
| 3 years | 27.4 | | 44.8 |
| 5 years | 27.4 | | 79 |
| 10 years | 27.4 | | 104 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yumi Nakagawa
DFI | Director of Finance/CFO | - | - |
Toyoda Kaichi
PSD | President | 62 | 28/02/2025 |
Yuji Matsushima
CTO | Chief Tech/Sci/R&D Officer | 51 | 30/06/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 31/05/2004 | |
Yoshirou Katae
BRD | Director/Board Member | 69 | 28/02/2022 |
Yoshihito Ohta
CHM | Chairman | 72 | 27/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | +2.07% | - | - | 2.63B | |
| -0.82% | +1.59% | -8.36% | -4.68% | 341B | |
| -0.44% | +5.52% | -9.21% | +5.31% | 140B | |
| -1.32% | +1.24% | +6.27% | +24.56% | 73.78B | |
| -0.29% | -1.50% | -23.03% | -21.58% | 49.81B | |
| +0.69% | +24.32% | +14.93% | -30.44% | 37.67B | |
| -0.51% | +2.87% | -10.55% | -18.30% | 37.32B | |
| +1.32% | +3.46% | +6.99% | +29.44% | 20.29B | |
| -0.18% | +4.58% | +9.95% | +10.56% | 20.09B | |
| +0.03% | +0.13% | -26.09% | -10.81% | 9.93B | |
| Average | +0.00% | +4.85% | -4.35% | -1.77% | 81.13B | |
| Weighted average by Cap. | -0.17% | +4.04% | -6.27% | -1.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 173B 1.08B 928M 868M 794M 1.5B 103B 1.51B 10.16B 3.98B 52.16B 4.07B 3.98B | 180B 1.13B 967M 905M 828M 1.56B 108B 1.58B 10.59B 4.15B 54.36B 4.24B 4.15B |
| Net income | 10.26B 64.39M 55.16M 51.62M 47.2M 89.08M 6.14B 89.91M 604M 237M 3.1B 242M 237M | 13.67B 85.86M 73.55M 68.82M 62.93M 119M 8.19B 120M 805M 316M 4.13B 323M 315M |
| Net Debt | -57.86B -363M -311M -291M -266M -503M -34.67B -507M -3.41B -1.34B -17.49B -1.36B -1.33B | -69.8B -438M -375M -351M -321M -606M -41.82B -612M -4.11B -1.61B -21.1B -1.65B -1.61B |
| Date | Price | Change |
|---|---|---|
| 25/08/26 | €29.60 | +0.68% |
| 24/08/26 | €29.40 | 0.00% |
| 21/08/26 | €29.40 | 0.00% |
| 20/08/26 | €29.40 | +1.38% |
| 19/08/26 | €29.00 | +0.69% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4967 Stock
- KOY Stock
Select your edition
All financial news and data tailored to specific country editions
